Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Wegener's granulomatosis

R A DeRemee1

  • 1Mayo Medical School, Rochester, Minnesota, USA.

Current Opinion in Pulmonary Medicine
|September 1, 1995
PubMed
Summary
This summary is machine-generated.

Wegener

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trimethoprim-sulphamethoxazole for the treatment of Wegener's granulomatosis.

Rheumatology (Oxford, England)·2003
Same author

Ahead to the past.

Mayo Clinic proceedings·1999
Same author

Colchicine versus prednisone in the treatment of idiopathic pulmonary fibrosis. A randomized prospective study. Members of the Lung Study Group.

American journal of respiratory and critical care medicine·1998
Same author

Dysphoria and sarcoidosis.

Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG·1998
Same author

Colchicine versus prednisone as treatment of usual interstitial pneumonia.

Mayo Clinic proceedings·1997
Same author

Carcinoid tumors and sarcoidosis--does a link exist?

Mayo Clinic proceedings·1997
Same journal

Nonsteroid treatment options in (pulmonary) sarcoidosis. When to consider and why?

Current opinion in pulmonary medicine·2026
Same journal

Multidisciplinary approach in cardiac sarcoidosis: to biopsy or not?

Current opinion in pulmonary medicine·2026
Same journal

Low diffusion capacity in pulmonary hypertension.

Current opinion in pulmonary medicine·2026
Same journal

Toward precision imaging in interstitial lung disease: advances in quantitative imaging and artificial intelligence.

Current opinion in pulmonary medicine·2026
Same journal

Oxygen therapy in interstitial lung disease - navigating benefit and burden.

Current opinion in pulmonary medicine·2026
Same journal

Preclinical and clinical advances in pulmonary hypertension associated with systemic sclerosis.

Current opinion in pulmonary medicine·2026
See all related articles

Area of Science:

  • Rheumatology
  • Immunology
  • Pathology

Background:

  • Wegener's granulomatosis, now known as granulomatosis with polyangiitis, has evolved significantly since its initial description.
  • The classic diagnostic triad is no longer considered essential for diagnosis.
  • A broader clinical spectrum is now recognized, incorporating diverse presentations.

Purpose of the Study:

  • To review the updated diagnostic criteria and classification for Wegener's granulomatosis.
  • To outline current treatment strategies based on disease extent and severity.
  • To highlight advancements in understanding the pathogenesis of the disease.

Main Methods:

  • Review of historical and current literature on Wegener's granulomatosis.
  • Analysis of the ELK (ear, nose, and throat; lung; kidney) classification system.

Related Experiment Videos

  • Examination of diagnostic markers, including histopathology and antineutrophil cytoplasmic antibodies (ANCA).

    • Main Results:

    • Diagnosis no longer requires the presence of all components of the Wegener's triad.
    • The ELK classification accommodates a wider range of clinical manifestations.
    • Antineutrophil cytoplasmic antibodies (ANCA) and pathological findings are crucial for diagnosis.
    • Treatment varies from trimethoprim-sulfamethoxazole for localized disease to glucocorticoids and cyclophosphamide for systemic involvement.

    Conclusions:

    • Wegener's granulomatosis diagnosis and classification have been refined.
    • Treatment protocols are tailored to disease severity and organ involvement.
    • Ongoing research into ANCA is providing deeper insights into disease mechanisms.